首页> 外文期刊>JACC. Cardiovascular interventions >A prospective randomized trial of thrombectomy versus no thrombectomy in patients with ST-segment elevation myocardial infarction and thrombus-rich lesions: MUSTELA (MUltidevice Thrombectomy in Acute ST-Segment ELevation Acute Myocardial Infarction) trial
【24h】

A prospective randomized trial of thrombectomy versus no thrombectomy in patients with ST-segment elevation myocardial infarction and thrombus-rich lesions: MUSTELA (MUltidevice Thrombectomy in Acute ST-Segment ELevation Acute Myocardial Infarction) trial

机译:ST段抬高型心肌梗塞和血栓丰富病变患者的血栓切除术与不行血栓切除术的前瞻性随机试验:MUSTELA(急性ST段抬高急性心肌梗死的多层器械血栓切除术)试验

获取原文
获取原文并翻译 | 示例
           

摘要

Objectives: The aim of this study was to evaluate whether thrombectomy during primary percutaneous coronary intervention (pPCI) in patients with high thrombus burden improves myocardial reperfusion and reduces infarct size. Background: Thrombectomy aims at reducing distal thrombotic embolization during pPCI, improving myocardial reperfusion and clinical outcome. Methods: We randomized 208 patients with high thrombus burden in a 1:1 ratio to either pPCI with thrombectomy (Group T) or standard pPCI (Group S). Thrombectomy was performed with either rheolytic or manual aspiration catheters. Three-month magnetic resonance imaging was performed to assess infarct size and transmurality and microvascular obstruction (MVO). The primary endpoints were ST-segment elevation resolution (STR) >70% at 60 min and 3-month infarct size. Results: The baseline profile was similar between groups, except for a higher rate of initial Thrombolysis In Myocardial Infarction flow grade 3 in Group S (p = 0.002). Group T showed a significantly higher rate of STR (57.4% vs. 37.3%; p = 0.004) and of final myocardial blush 3 (68.3% vs. 52.9%; p = 0.03). Group T and Group S did not differ with regard to infarct size (20.4 ± 10.5% vs. 19.3 ± 10.6%; p = 0.54) and transmurality (11.9 ± 12.0% vs. 11.6 ± 12.7%; p = 0.92), but Group T showed significantly less MVO (11.4% vs. 26.7%; p = 0.02) and a higher prevalence of inhomogeneous scar (p < 0.0001). One-year freedom from major adverse cardiac events was similar between groups. Conclusions: Thrombectomy as an adjunct to pPCI in patients with high thrombus load yielded better post-procedural STR and reduced MVO at 3 months but was not associated with a reduction in infarct size and transmurality. Thromboaspiration in Patients With High Thrombotic Burden Undergoing Primary Percutaneous (Coronary Intervention; NCT01472718)
机译:目的:本研究的目的是评估高血栓负荷患者在初次经皮冠状动脉介入治疗(pPCI)期间进行血栓切除术是否能改善心肌再灌注并减少梗塞面积。背景:血栓切除术旨在减少pPCI期间远端的血栓栓塞,改善心肌的再灌注和临床效果。方法:我们以1:1的比例将208例高血栓负担的患者随机分配至接受血栓切除术的pPCI(T组)或标准pPCI(S组)。血栓切除术采用流变导管或手动抽吸导管进行。进行了为期三个月的磁共振成像,以评估梗死面积,透壁性和微血管阻塞(MVO)。主要终点是60分钟和3个月的梗死面积时ST段抬高分辨率(STR)> 70%。结果:各组之间的基线情况相似,不同的是,S组中第3级心肌梗死患者的初始溶栓率更高(p = 0.002)。 T组显示STR(57.4%vs. 37.3%; p = 0.004)和最终心肌腮红3(68.3%vs. 52.9%; p = 0.03)的发生率明显更高。 T组和S组在梗死面积(20.4±10.5%vs. 19.3±10.6%; p = 0.54)和透壁性(11.9±12.0%vs. 11.6±12.7%; p = 0.92)方面没有差异,但组T显示出明显更少的MVO(11.4%vs. 26.7%; p = 0.02)和更高的异形疤痕患病率(p <0.0001)。两组之间从主要不良心脏事件获得的一年自由相似。结论:在血栓负荷高的患者中,血栓切除术作为pPCI的辅助措施可产生更好的术后STR值,并在3个月时MVO降低,但与梗死面积和透壁性的降低无关。初次经皮高血栓形成患者的血栓抽吸(冠状动脉介入; NCT01472718)

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号